Lower Insurer Fees, Eased Generic Drug Access in Obamacare Rule

Fees that health insurers must pay to sell plans on the Obamacare exchange would be reduced for the first time under a Trump administration proposal released Jan. 17.

Insurers would also be allowed to switch preferences to generic drugs mid-year, in an attempt to lower prescription costs.

“Reducing this user fee will reduce the premium each consumer pays in 2020,” Centers for Medicare & Medicaid Services Administrator Seema Verma said in a statement on the proposed rule, which lays out the requirements for 2020 Obamacare plans.

Reduced premiums and fees should in turn increase market stability, the CMS said in ...